Agios Pharmaceuticals, Inc.

(including Exhibit 99.1 and Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued January 12, 2026 99.2 Presentation at the 44th Annual J.P. Mo